Peter Michael Vestlev
Impact in
-
- Vascular Tumors and Angiosarcomas
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
-
- Sarcoma Diagnosis and Treatment
- Advanced Breast Cancer Therapies
Papers in
- Oncology 8
- Cancer Treatment and Pharmacology 4
- HER2/EGFR in Cancer Research 3
- Colorectal Cancer Treatments and Studies 2
- Bone health and treatments 2
- Cancer Diagnosis and Treatment 2
-
- Lung Cancer Treatments and Mutations 3
- Co-authors
- William P. Steward (1 shared paper)Jaap Verweij (1 shared paper)J. Buesa (1 shared paper)Andrés Poveda (1 shared paper)H.T. Mouridsen (1 shared paper)Richard Sylvester (1 shared paper)T. Wagener (1 shared paper)D. Thomas (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Acta Oncologica (2 papers)Cancer Research (2 papers)Molecular Cancer Therapeutics (1 paper)Annals of Oncology (1 paper)
- Partner nations
- DenmarkSpainNetherlands
In The Last Decade
Peter Michael Vestlev
11 papers receiving 152 citations
Peers
Comparison fields: 5 of 37
- Oncology 111
- Pulmonary and Respiratory Medicine 102
- Cancer Research 39
- Pathology and Forensic Medicine 21
- Cardiology and Cardiovascular Medicine 26
Countries citing papers authored by Peter Michael Vestlev
This map shows the geographic impact of Peter Michael Vestlev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Michael Vestlev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Michael Vestlev more than expected).
Fields of papers citing papers by Peter Michael Vestlev
This network shows the impact of papers produced by Peter Michael Vestlev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Michael Vestlev. The network helps show where Peter Michael Vestlev may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Michael Vestlev, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1991 | 85 | |
| 2 | 2017 | 47 | |
| 3 | 2020 | 9 | |
| 4 | 2020 | 6 | |
| 5 | 1992 | 3 | |
| 6 | Forebyggelse af skeletrelaterede hændelser hos patienter med knoglemetastaser ved solide tumorer | 2014 | 2 |
| 7 | 2022 | 1 | |
| 8 | 2020 | 1 | |
| 9 | 2014 | 1 | |
| 10 | [Prevention of skeletal related events in patients with bone metastases from solid tumours]. | 2014 | 1 |
| 11 | 2015 | 1 | |
| 12 | Is metronomic chemotherapy less toxic than conventional chemotherapy in the randomized phase 2 XeNa trial combining navelbine oral and Xeloda for HER2 negative breast cancer patients | 2015 | 0 |
| 13 | 2021 | 0 |
About Peter Michael Vestlev
Peter Michael Vestlev is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Surgery, having authored 13 papers that have together received 157 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Lung Cancer Treatments and Mutations (3 papers), HER2/EGFR in Cancer Research (3 papers), Colorectal Cancer Treatments and Studies (2 papers), Breast Cancer Treatment Studies (2 papers), Bone health and treatments (2 papers), Cancer Diagnosis and Treatment (2 papers) and Cancer Genomics and Diagnostics (1 paper). The work is most often cited by research in Oncology (111 citations), Pulmonary and Respiratory Medicine (102 citations), Cancer Research (39 citations), Pathology and Forensic Medicine (21 citations) and Cardiology and Cardiovascular Medicine (26 citations). Peter Michael Vestlev has collaborated with scholars based in Denmark, Spain and Netherlands. Frequent co-authors include William P. Steward, Jaap Verweij, J. Buesa, Andrés Poveda, H.T. Mouridsen, Richard Sylvester, T. Wagener, D. Thomas, A.T. van Oosterom and Erik Jakobsen. Their work appears in journals such as Journal of Clinical Oncology, Acta Oncologica, Cancer Research, Molecular Cancer Therapeutics and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.